| Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer V Punj, S Bhattacharyya, D Saint-Dic, C Vasu, EA Cunningham, J Graves, ... Oncogene 23 (13), 2367-2378, 2004 | 203 | 2004 |
| Nonparametric multiple comparison procedures for unbalanced one-way factorial designs X Gao, M Alvo, J Chen, G Li Journal of Statistical Planning and Inference 138 (8), 2574-2591, 2008 | 118 | 2008 |
| D-optimal designs for logistic models with three and four parameters G Li, D Majumdar Journal of Statistical Planning and Inference 138 (7), 1950-1959, 2008 | 67 | 2008 |
| On sample size calculation based on odds ratio in clinical trials H Wang, SC Chow, G Li Journal of Biopharmaceutical Statistics 12 (4), 471-483, 2002 | 47 | 2002 |
| Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection KP Singh, G Li, FS Mitrani-Gold, M Kurtinecz, J Wetherington, JF Tomayko, ... Antimicrobial agents and chemotherapy 57 (11), 5284-5290, 2013 | 37 | 2013 |
| Phase 1 dose‐escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L) D Parsons‐Rich, F Hua, G Li, C Kantaridis, DD Pittman, S Arkin Journal of Thrombosis and Haemostasis 15 (5), 931-937, 2017 | 30 | 2017 |
| Topical retapamulin in the management of infected traumatic skin lesions R Shawar, N Scangarella-Oman, MB Dalessandro, J Breton, M Twynholm, ... Therapeutics and Clinical Risk Management, 41-49, 2009 | 27 | 2009 |
| Some results on D-optimal designs for nonlinear models with applications G Li, D Majumdar Biometrika 96 (2), 487-493, 2009 | 23 | 2009 |
| Optimal designs for tumor regrowth models G Li, N Balakrishnan Journal of Statistical Planning and Inference 141 (2), 644-654, 2011 | 19 | 2011 |
| A group sequential type design for three‐arm non‐inferiority trials with binary endpoints G Li, S Gao Biometrical journal 52 (4), 504-518, 2010 | 17 | 2010 |
| A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily … T Tanus, NE Scangarella-Oman, M Dalessandro, G Li, JJ Breton, ... Advances in skin & wound care 27 (12), 548-559, 2014 | 15 | 2014 |
| Optimal and efficient designs for Gompertz regression models G Li Annals of the Institute of Statistical Mathematics 64, 945-957, 2012 | 15 | 2012 |
| Systematic review MK Wang, R Heo, PB Meyre, S Blum, L Park, L Birchenough, K Vuong, ... Clinical ethics, 2023 | 10* | 2023 |
| The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind … JF Tomayko, G Li, JJ Breton, N Scangarella-Oman, MB Dalessandro, ... Advances in skin & wound care 26 (3), 113-121, 2013 | 8 | 2013 |
| Phase 1b study to evaluate safety, tolerability, and maximum tolerated dose of PF-05230907 for intracerebral hemorrhage Y Silva Blas, MN Diringer, B Lo, J Masjuan, N Pérez de la Ossa, ... Stroke 52 (1), 294-298, 2021 | 5 | 2021 |
| Phase 3 adaptive trial design options in treatment of complicated urinary tract infection K Viele, LM Mundy, RB Noble, G Li, K Broglio, JD Wetherington Pharmaceutical Statistics 17 (6), 811-822, 2018 | 3 | 2018 |
| Escalating single doses of PF-05230907 (recombinant factor Xa variant FXaI16L) are safe and demonstrate hemostatic pharmacology in healthy volunteers S Arkin, F Hua, C Kantaridis, G Li, D Parsons-Rich, DD Pittman Blood 128 (22), 3781, 2016 | 3 | 2016 |
| SINGLE-DOSE PHARMACOKINETICS OF RETAPAMULIN IN YOUNG CHILDREN WITH UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS. JZ Zhu, M Dalessandro, R Paternoster, G Li, J Tomayko CLINICAL PHARMACOLOGY & THERAPEUTICS 87, S12-S13, 2010 | | 2010 |
| Molecular characterisation of meticillin-resistant Staphylococcus aureus nasal isolates from patients with uncomplicated skin infections: P935 R Shawar, N Scangarella, G Li, M Twynholm, M Dalessandro, J Breton, ... Clinical Microbiology & Infection 14, 2008 | | 2008 |
| Comparative antibacterial activity of retapamulin, cephalothin, gentamicin and erythromycin against Staphylococcus aureus, including molecularly characterised isolates of MRSA … N Scangarella, R Shawar, G Li, M Twynholm, M Dalessandro, J Breton, ... Clinical Microbiology & Infection 14, 2008 | | 2008 |
